These effects overlap, at least partially, with those reported for the neuropeptide oxytocin (OXT), and indeed it has been shown that OXT activates the MAPK pathway within the hypothalamic paraventricular nucleus (PVN) via transactivation of the epidermal growth factor receptor (EGFR) to regulate anxiety in male rats [3]. The gene discussed is EGFR; the disease is Anxiety.